NASDAQ:AMGN

Amgen Inc. (AMGN)

406.04
-0.05 (0.01%)
as of Sep 24, 2026, 8:00:00 pm Market Open.
107 watching
0
DON'T BUY
Majority of money is from 3 products. Want's more diversificaion. Good balance sheet though.
TOP PICK
Likes the health-care sector. One of the top companies. Has underperformed for a long time, but they are willing to be patient.
TOP PICK
A very rapidly growing company. Earnings per share growth is in excess of 20% yearly. PE ratio barely more than that.
TOP PICK
Under a cloud. Driven down because of generic drugs and imports from Canada. Medicare will be onerous. Powerful balance sheet.
TOP PICK
Health care should outperform in a rising interest rate environment. A premier company. Likes the pipeline that it has. Out-of-favor right now.
TOP PICK
(A top pick in Feb/04. Down a bit.) This sector has great prospects on a going forward basis but will be volatile on a short-term basis. A leader in their field. Good growth prospects.
TOP PICK
TOP PICK
A leading biotech company. Trading at 22 X next year's earnings. Pretty cheap for this quality of a company.
BUY
A very mature biotech company. Expects about 10/15% revenue growth and about 20/25% earnings growth. Trading at a low multiple.
PAST TOP PICK
(A top pick July 15/03. Down 13.7%.) Sold the stock in the summer.
TOP PICK
Has made some good acquisitions in the last couple of years, which has propped up their product line. 25 X next year's earnings.
BUY
They don't have the problem of drugs going off patent. The stock can go much higher. Dropping currently because the sector is pulling it down.
PAST TOP PICK
Was a top pick on Jun 4/03. Up 7%.) The leader in bio techs. Has grown its earnings every year since 1994.
TOP PICK
A lot of drug products in the pipeline. Cash flow is growing.
TOP PICK
Has made money every year going back to 1994. Good cash flow.
Showing 136 to 150 of 167 entries